neo7logix

Research, Development and Design of Personalized Peptide Therapy Solutions

CGMP Peptide Manufacturing

Neo7Bioscience ensures that all our products are designed and manufactured in adherence to all CGMP regulations to assure that the identity, strength, quality, and purity of our drug products meet or exceed all industry standards.

Product Description

  • PBIMA* (Precision Based Immuno-Molecular Augmentation) – Patented analytical pipeline that uses the results from NGS genetic analysis, RNA transcriptomics and urine proteomics to create specific peptide designs that address identified immune system deficiencies of the patient.
  • PBIMA-PES (Personalized Edited Sequences) - Custom personalized peptide formulation for the treatment of cancer, neurodegenerative or autoimmune diseases

PBIMA-PES

A personalized peptide-based vaccine for the treatment of cancer, neurodegenerative or autoimmune diseases.

Key Product Features

  • It consists of a personalized pool of custom designed peptides and carefully selected nanocatalysts.
  • Peptide selection is based on information gathered from analysis of a patient’s blood, urine and tumor samples.
  • Patent pending PBIMA analysis pipeline is used to map and rank potential peptides for effectiveness against disease indicators.
  • Short peptide sequences significantly reduce the potential for adverse immune system responses or side effects.
  • Recommended precision-matched drugs, natural agents and plant-based medicines are included in the patient’s personalized report.